Conversational Recasting for Language Developmental Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the best ways to teach grammar to preschool children with developmental language disorders. Researchers are testing two methods to determine which helps children learn grammar more effectively: starting with grammar they sometimes use correctly or starting with grammar they rarely use. Children will receive one-on-one sessions for six weeks, with progress checks throughout and after the treatment. This trial may suit a child who is a native English speaker, has passed a hearing screening, and shows signs of difficulty with grammar. The primary treatment being tested is Conversational Recasting, a therapy focused on correcting morphological errors in speech. As an unphased trial, this study offers a unique opportunity to contribute to educational research and potentially improve language teaching methods for children.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that this teaching method is safe for children with developmental language disorders?
Research has shown that conversational recasting, a technique to assist children with language disorders, is generally safe. This method involves repeating a child's words with correct grammar, aiding in their learning of proper language use over time.
Studies have found that conversational recasting is more effective than some other methods, such as imitative treatment, for children with specific language issues. However, these studies primarily focus on effectiveness rather than risks. No specific evidence indicates significant negative effects from using conversational recasting.
This trial is in the "Not Applicable" phase, meaning the treatment is still being tested for effectiveness, not safety. While the treatment is new and promising, information on negative outcomes remains limited. However, its use in educational settings suggests it is generally considered safe.12345Why are researchers excited about this trial?
Researchers are excited about conversational recasting for language developmental disorders because it offers a personalized approach to language learning. Unlike traditional speech therapy, which often employs a one-size-fits-all method, conversational recasting tailors treatment based on each child's current grammatical abilities. This method emphasizes natural language use, helping children improve their grammar by focusing on forms they struggle with and gradually advancing to more challenging ones. By targeting specific grammatical forms and adapting as the child progresses, conversational recasting has the potential to be more effective and engaging than standard interventions.
What evidence suggests that Conversational Recasting might be an effective treatment for language developmental disorders?
Research has shown that conversational recasting effectively helps children develop their grammar. Studies indicate that children often learn grammar faster with this method. Adults repeat a child's incorrect sentence in the correct way, aiding the child in learning the correct form. This trial will compare two approaches: the "Hard first" arm, where children receive treatment for a grammatical form used accurately less than 30% of the time, and the "Easy first" arm, where treatment targets a grammatical form used correctly at least 60% of the time. This technique has improved language skills in children with language development disorders, although its effectiveness can vary depending on the specific grammar being taught. Overall, conversational recasting has a strong track record for helping children learn grammar.16789
Are You a Good Fit for This Trial?
This trial is for native English-speaking preschool children aged 4-6 with developmental language disorders. They must be able to attend daily treatment, have normal hearing, specific scores on language and cognition tests, clear speech articulation, and frequent grammar mistakes that need correction.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Children receive one-on-one behavioral treatment focusing on grammatical forms over a six-week period
Follow-up
Participants are monitored for retention of trained and untrained grammatical forms approximately six weeks after treatment ends
What Are the Treatments Tested in This Trial?
Interventions
- Conversational recasting
Trial Overview
The study is testing conversational recasting as a teaching method to help children learn parts of grammar they struggle with. Over six weeks, the effectiveness of starting with easier or harder grammatical forms will be compared by assessing the children's use of these forms during and after treatment.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Children are treated for an emergent grammatical form that is used correctly at least 60% during three pre-treatment probe sessions. This form is treated until children generalize it's use an average of 90% or more across 3 probe sessions. Their treatment target is then switched to a grammatical form that is used less than 30% correct across 3 pre-treatment probe sessions.
Children are treated for a grammatical form that is used accurately less than 30% of the time during 3 pre-treatment probe sessions. This form is treated until children generalize it's use an average of 90% or more across 3 probe sessions. Their treatment target is then switched to a grammatical form that is used less than 30% correct across 3 pre-treatment probe sessions.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Arizona
Lead Sponsor
Published Research Related to This Trial
Citations
What Matters When Providing Conversational Recast ...
Conversational recasting treatment is generally effective. However, different versions of this treatment and different targets may yield different outcomes ...
The Efficacy of Recasts in Language Intervention
This systematic review and meta-analysis critically evaluated the research evidence on the effectiveness of conversational recasts in grammatical development
What Matters When Providing Conversational Recast ...
Conversational recasting treatment is generally effective. However, different versions of this treatment and different targets may yield different outcomes ...
Less Versus More: The Effect of Recast Length in ...
This study tests the potential effect of clinicians' recast length on child learning during a recast treatment.
(PDF) Effects of Imitative and Conversational Recasting ...
The results indicated: (a) Target acquisition was more rapid under conversational recast treatment for both groups. (b) This outcome held for targets absent ...
What Matters When Providing Conversational Recast ...
These conditions resulted in probe performance that was between 47% and 84% worse than performance of children who received enhanced ...
Recast Therapy for Treating Syntax in Bilingual Children ...
The purpose of this study is to examine the feasibility of the delivery of complex syntax recast therapy via telepractice to Spanish–English bilingual children.
Recast Therapy vs. Book Reading for Developmental ...
Conversational recast treatment was found to be more effective than imitative treatment for helping both children with specific language impairment (SLI) and ...
9.
researchgate.net
researchgate.net/publication/384535901_What_Matters_When_Providing_Conversational_Recast_Treatment_A_Multilevel_Modeling_AnalysisWhat Matters When Providing Conversational Recast ...
These conditions resulted in probe performance that was between 47% and 84% worse than performance of children who received Enhanced ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.